A randomized controlled trial evaluating effects on health for individuals with mobility disability: eHealth vs. standard care

Conditions

Self-reported mobility disability Signs and Symptoms Mobility disability

Lampousi AM, Berglind D, Forsell Y.

2020-11-164 citations

The Effect of Smartphone Apps Versus Supervised Exercise on Physical Activity, Cardiorespiratory Fitness, and Body Composition Among Individuals With Mild-to-Moderate Mobility Disability: Randomized Controlled Trial

Daniel Berglind, Diego Yacamán-Méndez, Catharina Lavebratt, Yvonne Forsell

JMIR mhealth and uhealth2019-10-2319 citations

10.2196/14615

An eHealth program versus a standard care supervised health program and associated health outcomes in individuals with mobility disability: study protocol for a randomized controlled trial.

Berglind D, Nyberg G, Willmer M, Persson M, Wells M, Forsell Y.

2018-04-276 citations

10.1186/s13063-018-2646-z

Interventions

A block randomized control design allocates the sample of young adults with MD into two equal groups. Those in the eHealth group have a low-cost 12 week walking and exercise programme delivered via sm

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Classified with a mobility disability, acquired within the past three years 2. Aged 18-35 years

Exclusion criteria

Exclusion criteria: 1. Problems walking

Design outcomes

Primary

Measure	Time frame
Levels of moderate to vigorous physical activity (MVPA) measured by the Actigraph GT3X+ accelerometer at baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention	—

Secondary

Measure	Time frame
1. Health related quality of life is measured by SF-36 at baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention 2. Musculoskeletal pain is measured by visual analogue scale (VAS) at baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention 3. Perceived stress is measured by the perceived stress scale at baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention 4. Symptoms of depression is measured by the Beck Depression Inventory-II baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention 5. Eating behavior is measured by a 24 hour recall questionnaire at baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention 6. Workability is measured by the symptom of depression questionnaire (SDQ) at baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention 7. Body composition is measured by bioelectrical impedence (BIA), weight, height, and waist circumference measures at baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention 8. Fitness is measured by the Elin-Ekbom-Bak submaximal VO2max test at baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention 9. Blood samples will be taken for genetic/epigenetic analysis at baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention.	—

Measure

Time frame

1. Health related quality of life is measured by SF-36 at baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention 2. Musculoskeletal pain is measured by visual analogue scale (VAS) at baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention 3. Perceived stress is measured by the perceived stress scale at baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention 4. Symptoms of depression is measured by the Beck Depression Inventory-II baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention 5. Eating behavior is measured by a 24 hour recall questionnaire at baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention 6. Workability is measured by the symptom of depression questionnaire (SDQ) at baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention 7. Body composition is measured by bioelectrical impedence (BIA), weight, height, and waist circumference measures at baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention 8. Fitness is measured by the Elin-Ekbom-Bak submaximal VO2max test at baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention 9. Blood samples will be taken for genetic/epigenetic analysis at baseline, 6 weeks (midpoint of intervention), 12 weeks (endpoint of intervention) and 12 months post intervention.

—

Countries

Sweden

Outcome results

None listed